CONGRESS GUIDE

ERS International Congress 2016
DETAILED PROGRAMME
MONDAY 05 SEPTEMBER, 2016
12:23
Epigenetic modulation of right ventricular failure
Roxane Paulin (Quebec, Canada)
Room E Session 350 10:45 - 12:45
Symposium: Respiratory syncytial virus: new therapies, but what impact?
Aims : The aims of this session are to help the audience understand the scale and impact of respiratory syncytial virus (RSV) infection in
developed and developing nations; describe the many Phase I and II trials that are currently testing strategies for treating and preventing
RSV; and debate the potential impact that such therapies may have on future respiratory health.
Track(s) : Paediatric
Tag(s) : Clinical
Target audience : Allied health professional, Clinician, Emergency medicine doctor, General practitioner, Immunologist, Junior member,
Microbiologist, Neonatologist, Nurse, Paediatrician, Patient, Pharmaceutical industry representative, Public health official, Pulmonologist,
Student
Chairs : Jonathan Grigg (London, United Kingdom), Nicolas Regamey (Luzern 16, Switzerland)
1938
10:45
11:15
11:45
Global scale and impact of RSV infection
Harish Nair (Edinburgh, United Kingdom)
Matching RSV treatments and vaccines to target groups
Peter Openshaw (LONDON, United Kingdom)
Reducing RSV infection will have a significant impact on future respiratory health: pro
Louis Bont (Utrecht, Netherlands)
1939
1940
1941
12:15
Reducing RSV infection will have a significant impact on future respiratory health: con
Hans Bisgaard (Copenhagen, Denmark)
Prince Regent Room Session 351 10:45 - 12:45
Symposium: Influenza and respiratory physicians
A joint ERS/ESWI symposium
Aims : The aims of this session are to describe the epidemiology of influenza infection; examine the factors that increase the risk of
influenza infection; and discuss new and potential future therapies.
Track(s) : Epidemiology / Environment Infection
Tag(s) : Translational
Target audience : Allergologist, Clinician, Epidemiologist, Fellow, General practitioner, Immunologist, Junior member, Microbiologist,
Paediatrician, Patient, Pharmaceutical industry representative, Physiologist, Public health official, Pulmonologist, Researcher, Respiratory
physician, Scientist, Student, Trainee
Chairs : Gernot G.U. Rohde (Maastricht, Netherlands), Susanne Herold (GIESSEN, Germany)
1942
10:45
11:15
11:45
Epidemiology of flu in the last decade: trends and fears
Albert Osterhaus (Hannover, Germany)
Protecting high-risk individuals against flu
Janet McElhaney (Farmington, United States of America)
Management of the critically-ill influenza patient
Marcos I. Restrepo (San Antonio, United States of America)
1943
1944
1945
12:15
Who gets severe influenza, and why
Peter Openshaw (LONDON, United Kingdom)
Room L Session 352 10:45 - 12:45
Symposium: Molecular footprints in lung cancer diagnosis and management
Aims : To examine the evidence behind current perceptions of molecular biomarkers, genetics, and genomics in thoracic oncology; to
provide an overview of the cutting-edge research in terms of lung cancer treatment.
Track(s) : Oncology
Tag(s) : Translational
Target audience : Allied health professional, Clinician, Epidemiologist, Fellow, General practitioner, Junior member, Nurse, Oncologist,
Pathologist, Patient, Public health official, Pulmonologist, Radiologist, Researcher, Resident, Respiratory physician, Scientist, Student,
Thoracic endoscopist, Thoracic surgeon, Trainee
1946
136 26.08.2016